Free Trial

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) Stock to Pay Quarterly Dividend of $0.30

Sabra Healthcare REIT logo with Real Estate background
Image from MarketBeat Media, LLC.

Key Points

  • Sabra Healthcare REIT declared a quarterly dividend of $0.30 per share, payable November 30 to shareholders of record on November 13. The dividend implies $1.20 in annual payments and a 6.0% yield.
  • The company’s reported EPS of $0.11 missed the $0.16 consensus estimate and fell from $0.38 a year earlier, although revenue rose 31.4% year over year to approximately $249.6 million.
  • 2026 earnings guidance was raised to $1.54–$1.55 per share, while funds from operations and adjusted funds from operations remained solid; however, the current 153.8% earnings payout ratio indicates the dividend is not fully covered by reported earnings.
  • Five stocks to consider instead of Sabra Healthcare REIT.

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA - Get Free Report) announced a quarterly dividend on Monday, November 2nd. Shareholders of record on Friday, November 13th will be given a dividend of $0.30 per share by the real estate investment trust on Monday, November 30th. This represents a $1.20 annualized dividend and a dividend yield of 6.0%. The ex-dividend date of this dividend is Friday, November 13th.

Sabra Healthcare REIT has a dividend payout ratio of 153.8% indicating that the company cannot currently cover its dividend with earnings alone and is relying on its balance sheet to cover its dividend payments. Equities research analysts expect Sabra Healthcare REIT to earn $1.60 per share next year, which means the company should continue to be able to cover its $1.20 annual dividend with an expected future payout ratio of 75.0%.

Sabra Healthcare REIT Stock Up 1.7%

NASDAQ SBRA traded up $0.34 on Tuesday, hitting $20.07. The stock had a trading volume of 1,704,008 shares, compared to its average volume of 2,658,420. The business's fifty day moving average price is $19.86 and its 200 day moving average price is $19.96. Sabra Healthcare REIT has a 52-week low of $17.53 and a 52-week high of $22.77. The stock has a market cap of $5.13 billion, a price-to-earnings ratio of 77.29, a price-to-earnings-growth ratio of 1.73 and a beta of 0.63. The company has a debt-to-equity ratio of 0.95, a current ratio of 3.07 and a quick ratio of 3.07.

Sabra Healthcare REIT (NASDAQ:SBRA - Get Free Report) last posted its quarterly earnings data on Monday, November 2nd. The real estate investment trust reported $0.11 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.16 by ($0.05). The company had revenue of $249.57 million for the quarter, compared to analyst estimates of $236.64 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business's revenue was up 31.4% compared to the same quarter last year. During the same quarter last year, the company earned $0.38 EPS. Equities research analysts anticipate that Sabra Healthcare REIT will post 1.52 earnings per share for the current year.

Key Sabra Healthcare REIT News

Here are the key news stories impacting Sabra Healthcare REIT this week:

  • Positive Sentiment: 2026 earnings guidance was raised. Sabra now expects full-year EPS of $1.54–$1.55, above the consensus estimate of $1.52, signaling improved confidence in its operating performance. Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance
  • Positive Sentiment: Third-quarter revenue and funds from operations exceeded expectations. Revenue increased 31.4% year over year to approximately $249.6 million, surpassing the roughly $236.6 million analyst estimate. Quarterly FFO was $0.40 per share, above the $0.38 reported a year earlier and slightly ahead of the $0.40 consensus estimate cited by Zacks. Sabra Healthcare Tops Q3 FFO and Revenue Estimates
  • Positive Sentiment: Cash-flow metrics remained solid. Sabra reported normalized FFO of $0.39 per share, AFFO of $0.45 and normalized AFFO of $0.41. The company also announced a quarterly dividend, supporting the stock’s income appeal. Sabra Reports Third-Quarter Results and Declares Quarterly Dividend
  • Negative Sentiment: Reported EPS missed estimates. Net income was $0.11 per diluted share, below the $0.16 consensus and down from $0.38 a year ago. The earnings decline and low reported net margin could limit the upside reaction despite stronger revenue, FFO and guidance. Sabra Health Care REIT Third-Quarter Results

About Sabra Healthcare REIT

(Get Free Report)

Sabra Healthcare REIT, Inc is a self-managed real estate investment trust that owns and invests in healthcare-related real estate. The company focuses primarily on properties used for skilled nursing and transitional care, senior housing, behavioral health, specialty hospitals and other healthcare services.

Sabra leases properties to healthcare operators and also provides capital through loans, joint ventures and other real estate investments. Its portfolio is designed to support a range of care settings, including facilities serving seniors, patients requiring rehabilitation and individuals receiving behavioral healthcare.

Founded in 2010 and headquartered in Irvine, California, Sabra has expanded through acquisitions, development investments and strategic transactions, including its 2017 combination with Care Capital Properties.

Read More

Dividend History for Sabra Healthcare REIT (NASDAQ:SBRA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Sabra Healthcare REIT Right Now?

Before you consider Sabra Healthcare REIT, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sabra Healthcare REIT wasn't on the list.

While Sabra Healthcare REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines